De-escalation from Dose-Intensified Anti-TNF Therapy Is Successful in the Majority of IBD Patients at 12 Months. Little RD, Chu IE, Ward MG, Sparrow MP, et al. Dig Dis Sci 2022;67:259-262.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Little RD, Chu IE, Ward MG, Sparrow MP, et al. De-escalation from Dose-Intensified Anti-TNF Therapy Is Successful in the Majority of IBD Patients at 12 Months. Dig Dis Sci 2022;67:259-262.
PMID: 33763785